Breaking News Instant updates and real-time market news.

GTHX

G1 Therapeutics

$35.55

1.32 (3.86%)

09:15
03/13/18
03/13
09:15
03/13/18
09:15

G1 Therapeutics price target raised to $42 from $34 at Needham

Needham analyst Chad Messer raised his price target on G1 Therapeutics to $42 after the company reported a "strong" top line data for trilaciclib last week showing significant reduction in treatment emergent adverse events when added to chemotherapy. Messer keeps his Buy rating on G1 Therapeutics and attributes the price increase to the base case trilaciclib market forecast, adding that his sales forecasts are based on U.S. sales expectations alone even though G1 can partner on the rights to its programs internationally.

GTHX G1 Therapeutics
$35.55

1.32 (3.86%)

02/05/18
JPMS
02/05/18
NO CHANGE
Target $30
JPMS
Overweight
G1 Therapeutics price target raised to $30 from $24 at JPMorgan
JPMorgan analyst Anupam Rama raised his price target for G1 Therapeutics to $30 ahead of the trilaciclib Phase 2 data for the treatment of front-line small cell lung cancer. The analyst continues to view trilaciclib as a "differentiated underappreciated asset." He also continues to see a "high probability of an upside scenario" ranging from 30%-50%. Downside in the stock could range from 15%-20% on mixed data to 35%-plus if trilaciclib is taken out of the model completely, Rama tells investors in a research note.
12/19/17
BTIG
12/19/17
INITIATION
Target $38
BTIG
Buy
G1 Therapeutics initiated with a Buy at BTIG
BTIG analyst Dane Leone started G1 Therapeutics with a Buy rating and $38 price target.
06/12/17
WEDB
06/12/17
INITIATION
WEDB
Outperform
G1 Therapeutics initiated with an Outperform at Wedbush
Wedbush analyst David M. Nierengarten started coverage of G1 Therapeutics with a $33 price target and an Outperform rating. He says that the company's two lead programs based on CDK 4/6 inhibition have "compelling" opportunities and both can generate sales of more than $1B. Designed to prevent division of bone marrow stem cells, Trilaciclib has been shown to be effective while having "none of the complications" associated with HGF therapy, according to the analyst. G1T38 "could be safer and more potent than Ibrance, which generated more than $2B in sales last year" according to the analyst.
06/12/17
NEED
06/12/17
INITIATION
Target $34
NEED
Buy
G1 Therapeutics initiated with a Buy at Needham
Needham analyst Chad Messer started G1 Therapeutics with a Buy rating and $34 price target, noting that the company's lead cancer drug programs are still relatively early stage but he sees "multiple opportunities" for shares to advance through the first half of next year as the company reports data from trials.

TODAY'S FREE FLY STORIES

DVN

Devon Energy

$27.20

-0.54 (-1.95%)

06:08
12/10/18
12/10
06:08
12/10/18
06:08
Downgrade
Devon Energy rating change  »

Devon Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHI

National Health Investors

$80.44

0.31 (0.39%)

06:08
12/10/18
12/10
06:08
12/10/18
06:08
Hot Stocks
National Health Investors announces $25.35M development project in Wisconsin »

National Health Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIG

Big Lots

06:07
12/10/18
12/10
06:07
12/10/18
06:07
Recommendations
Big Lots analyst commentary  »

Big Lots price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUBC

Subsea 7 SA

$0.00

(0.00%)

06:07
12/10/18
12/10
06:07
12/10/18
06:07
Upgrade
Subsea 7 SA rating change  »

Subsea 7 SA upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

06:07
12/10/18
12/10
06:07
12/10/18
06:07
Upgrade
TechnipFMC rating change  »

TechnipFMC upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

WAGE

WageWorks

06:06
12/10/18
12/10
06:06
12/10/18
06:06
Upgrade
WageWorks rating change  »

WageWorks upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

COF

Capital One

$82.66

-1.93 (-2.28%)

06:06
12/10/18
12/10
06:06
12/10/18
06:06
Upgrade
Capital One rating change  »

Capital One upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

RDWR

Radware

$22.34

-0.35 (-1.54%)

06:06
12/10/18
12/10
06:06
12/10/18
06:06
Hot Stocks
Radware announces major deal with global cloud provider »

Radware announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWKS

Skyworks

$67.56

-3.04 (-4.31%)

06:06
12/10/18
12/10
06:06
12/10/18
06:06
Downgrade
Skyworks rating change  »

Skyworks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

$61.16

-1.58 (-2.52%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Downgrade
Qorvo rating change  »

Qorvo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

IMOS

ChipMOS

$17.20

-0.69 (-3.86%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Earnings
Breaking Earnings news story on ChipMOS »

ChipMOS reports November…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GV

Goldfield Corp

$2.32

-0.035 (-1.49%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Hot Stocks
Goldfield Corp announces resumption of stock repurchase program »

The Goldfield Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCWX

Secureworks

$15.65

-1.52 (-8.85%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Downgrade
Secureworks rating change  »

Secureworks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Periodicals
Ghosn, Nissan formally indicted in Japan, Bloomberg reports »

Carlos Ghosn and Nissan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

SNN

Smith & Nephew

$37.97

0.76 (2.04%)

06:05
12/10/18
12/10
06:05
12/10/18
06:05
Upgrade
Smith & Nephew rating change  »

Smith & Nephew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADS

Alliance Data

$180.43

-6.725 (-3.59%)

06:04
12/10/18
12/10
06:04
12/10/18
06:04
Upgrade
Alliance Data rating change  »

Alliance Data upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

SNCR

Synchronoss

06:04
12/10/18
12/10
06:04
12/10/18
06:04
Upgrade
Synchronoss rating change  »

Synchronoss upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABB

ABB

$18.86

-0.375 (-1.95%)

06:04
12/10/18
12/10
06:04
12/10/18
06:04
Upgrade
ABB rating change  »

ABB upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

EQT

EQT Corporation

$18.42

0.41 (2.28%)

06:04
12/10/18
12/10
06:04
12/10/18
06:04
Hot Stocks
Rice leadership team sends letter to EQT Corporation detailing path forward »

Toby Z. Rice and Derek A.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

X

U.S. Steel

$21.30

-0.7 (-3.18%)

06:03
12/10/18
12/10
06:03
12/10/18
06:03
Upgrade
U.S. Steel rating change  »

U.S. Steel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVTY

Tivity Health

$40.60

-0.27 (-0.66%)

, NTRI

Nutrisystem

$34.19

-1.07 (-3.03%)

06:02
12/10/18
12/10
06:02
12/10/18
06:02
Hot Stocks
Breaking Hot Stocks news story on Tivity Health, Nutrisystem »

Tivity Health to acquire…

TVTY

Tivity Health

$40.60

-0.27 (-0.66%)

NTRI

Nutrisystem

$34.19

-1.07 (-3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$263.68

-5.98 (-2.22%)

06:01
12/10/18
12/10
06:01
12/10/18
06:01
Periodicals
President Xi tells lieutenants to 'follow through' on Trump agreement, WSJ says »

Chinese officials have…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$263.68

-5.98 (-2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGVT

Ingevity

$85.15

-5.32 (-5.88%)

05:58
12/10/18
12/10
05:58
12/10/18
05:58
Hot Stocks
Ingevity to acquire Capa caprolactone division of Perstorp Holding AB »

Ingevity announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$36.52

-0.33 (-0.90%)

05:58
12/10/18
12/10
05:58
12/10/18
05:58
Hot Stocks
TSMC reports November revenue NT$98.39B, up 5.6% y/y »

TSMC announced its net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COR

CoreSite Realty

$97.28

-2 (-2.01%)

, DLR

Digital Realty

$115.80

-1.135 (-0.97%)

05:53
12/10/18
12/10
05:53
12/10/18
05:53
Downgrade
CoreSite Realty, Digital Realty, Equinix rating change  »

CoreSite Realty…

COR

CoreSite Realty

$97.28

-2 (-2.01%)

DLR

Digital Realty

$115.80

-1.135 (-0.97%)

EQIX

Equinix

$386.76

-6.1 (-1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.